Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.0152
+0.0022 (16.92%)
At close: Oct 16, 2026

Nascent Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Oct '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
2162149
Market Cap Growth
12.54%-85.56%-72.61%430.37%-57.01%-69.99%
Enterprise Value
-1823331114
Last Close Price
0.020.031.307.509.7558.05

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Oct '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Forward PE
-7.007.00---
PS Ratio
2.130.390.864.562.323.99
PB Ratio
--0.832.133.742.681.38

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Oct '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-8.263.407.126.496.23

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Oct '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.92-9.163.461.301.410.02
Net Debt / Equity Ratio
-0.92-9.133.431.221.100.01
Net Debt / EBITDA Ratio
-1.33-1.50-0.73-0.70-0.24-0.01
Net Debt / FCF Ratio
36.54-6.93-2.35-0.85-0.81-0.02
Asset Turnover
0.140.170.420.450.310.42
Inventory Turnover
2.470.991.781.110.491.37
Quick Ratio
0.120.340.540.431.112.57
Current Ratio
0.140.480.700.701.276.70
Return on Equity (ROE)
--1148.32%-358.87%-343.02%-218.54%-116.40%
Return on Assets (ROA)
-62.52%-36.43%-55.28%-62.95%-84.68%-67.52%
Return on Capital Employed (ROCE)
76.30%747.20%-451.80%-146.40%-446.90%-87.80%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Oct '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-602.01%-1172.96%-259.58%-57.98%-224.36%-64.10%
FCF Yield
11.19%-158.94%-68.66%-38.14%-50.47%-38.22%
Buyback Yield / Dilution
-608.91%-252.66%-165.79%-470.01%-71.71%-45.69%